STEWART ABBOT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEWART ABBOT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEWART ABBOT. STEWART ABBOT is Chief Development Officer in FATE THERAPEUTICS INC ($FATE) and See Remarks in Adicet Bio, Inc. ($TORC).
Latest Insider Trading Transactions of STEWART ABBOT
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 16.82 | 106,900 | 1,798,058 | 106,900 | |
| Jan 15 2021 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 13.27 | 80,000 | 1,061,600 | 80,000 | |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 16.11 | 63,751 | 1,027,029 | 63,751 | |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 5.97 | 57,151 | 341,191 | 57,151 | |
| Sep 17 2020 | TORC | Adicet Bio, Inc. | ABBOT STEWART | See Remarks | Option Exercise | A | 2.26 | 84,791 | 191,628 | 84,791 | |
| May 16 2018 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Option Exercise | M | 6.90 | 18,138 | 125,152 | 51,862 | |
| May 16 2018 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Option Exercise | M | 4.89 | 2,916 | 14,259 | 67,084 | |
| May 16 2018 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Buy | M | 6.90 | 18,138 | 125,152 | 64,917 | 46.8 K to 64.9 K (+38.77 %) |
| May 16 2018 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Buy | M | 4.89 | 2,916 | 14,259 | 46,779 | 43.9 K to 46.8 K (+6.65 %) |
| Jan 17 2018 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Option Exercise | A | 6.55 | 186,000 | 1,218,300 | 186,000 | |
| Jan 12 2016 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Option Exercise | A | 2.90 | 148,800 | 431,520 | 148,800 | |
| Jan 12 2016 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Grant | A | 0.00 | 3,863 | 0 | 43,863 | 40 K to 43.9 K (+9.66 %) |
| Oct 16 2015 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Option Exercise | A | 4.89 | 70,000 | 342,300 | 70,000 | |
| Oct 16 2015 | FATE | FATE THERAPEUTICS ... | ABBOT STEWART | Chief Development O ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Page: 1